Sign up here and take full advantage of MicrobiomePost‘s features.
Sign up

Bloom Science plans to develop microbial treatment for epilepsy

Christopher Reyes, CEO, Co-Founder and Director at Bloom Science, spoke about the new class of microbe-based therapeutics for neurological disorders the company is working on.

During the 8th Microbiome Movement – Drug Development Summit, held in London at the end of January, MicrobiomePost discussed with Christopher Reyes, CEO, Co-Founder and Director at Bloom Science, about the new class of microbe-based therapeutics for neurological disorders the company is working on.

Most recent

HCPs Area

Industry

MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome

Published by Clorofilla Srl

Facebook-f Linkedin Twitter Youtube
© 2016-2024 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomePost’s Privacy Policy